The Leadership Team at Oblique Therapeutics is responsible for steering the company's strategic direction, overseeing the development of innovative antibody-based therapies, and ensuring efficient resource allocation. They collaborate across functions to align clinical, financial, and business objectives, driving initiatives that promote the advancement of chronic pain and metastatic cancer treatments. Their collective expertise fosters a culture of innovation and accountability, essential for achieving the company's mission.
View all